On Wednesday, Jill Biden announced USD 100 million in federal financing for research and development into women’s health as part of a new White House effort she is leading.
The financing is the first significant outcome of the White House Initiative on Women’s Health Research, which was unveiled late last year. The money comes from the Advanced Research Projects Agency for Health, or ARPA-H, which is part of the federal Department of Health and Human Services. The first lady was scheduled to unveil the ARPA-H Sprint for Women’s Health during an event in Cambridge, Massachusetts, on Wednesday.
Biden has stated that women do not know enough about their health since research has historically been neglected and inadequate. The White House program attempts to shift the focus and enhance women’s health research financing. “We will close the gaps, accelerate new ideas, and change women’s lives,” the first lady will say, according to extracts from her prepared speech obtained by The Associated Press.
“We will build a health care system that puts women and their lived experiences at its center, one where no woman or girl has to hear that it’s all in your head,’ or, it’s just stress;’ where women aren’t just an after-thought, but a first-thought; and where women don’t just survive, they lead long, healthy, and happy lives,” she said.
President Joe Biden established the Advanced Research Projects Agency for Health in 2022 to advance health-related solutions. He referred to the agency as part of his “unity agenda.” According to the White House, the agency will request proposals for revolutionary research and development to improve women’s health in the coming weeks. When the White House project was unveiled last year, the First Lady said it stemmed from a meeting with Maria Shriver, a women’s health champion and former California First Lady.
Shriver, Biden claimed, spoke of the necessity for a public-private partnership to fill gaps in women’s health research. Jill Biden, together with the White House Gender Policy Council, leads the White House Initiative on Women’s Health Research.
According to Deloitte, the global healthcare business is set to undergo considerable changes in 2024. The future of global health care might be determined by: innovation, sustainability, social care integration, cost management, and workforce adaption.
Clearstate predicts that the healthcare industry’s expenditure growth will resume in 2024 when the global economy recovers. However, issues will persist since it will be exposed to headwinds such as limited resources, tougher restrictions, and ongoing strikes.
According to McKinsey, customers are gaining more control over their health and want corporations to give effective, science-backed solutions.
